Edition:
United States

Aileron Therapeutics Inc (ALRN.OQ)

ALRN.OQ on NASDAQ Stock Exchange Global Market

2.36USD
4:00pm EDT
Change (% chg)

$-0.24 (-9.23%)
Prev Close
$2.60
Open
$2.62
Day's High
$2.68
Day's Low
$2.30
Volume
77,235
Avg. Vol
19,644
52-wk High
$15.34
52-wk Low
$1.98

Chart for

About

Aileron Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing a class of therapeutics called stapled peptides. It is also developing a pipeline of stapled peptide drugs across a range of therapeutic areas, including cancer, endocrine and... (more)

Overall

Beta: --
Market Cap(Mil.): $29.47
Shares Outstanding(Mil.): 14.74
Dividend: --
Yield (%): --

Financials

  ALRN.OQ Industry Sector
P/E (TTM): -- 98.72 30.39
EPS (TTM): -2.05 -- --
ROI: -142.13 0.92 12.61
ROE: -- -0.89 14.80

BRIEF-Aileron Therapeutics Names John Longenecker As Interim CEO

* AILERON THERAPEUTICS INC - JOHN P. LONGENECKER HAS BEEN NAMED INTERIM CHIEF EXECUTIVE OFFICER

May 15 2018

BRIEF-Aileron Therapeutics Q1 Loss Per Share $0.52

* AILERON THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 09 2018

BRIEF-Aileron Therapeutics Reports Q4 Loss Of $0.47 Per Share

* AILERON THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Apr 02 2018

BRIEF-Aileron Therapeutics Appoints Jeffrey Bailey As Chairman Of Board

* AILERON THERAPEUTICS APPOINTS JEFFREY A. BAILEY TO ITS BOARD OF DIRECTORS

Mar 19 2018

Earnings vs. Estimates